Prevalence and Predictors of Osteoporosis in Patients of Interstitial Lung Disease: An Observational Study from North India

Background: Osteoporosis has been widely reported in chronic respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis. However, there is a scarcity of data on its prevalence and risk factors in interstitial lung disease (ILD), particularly in Indian patients. Aims: The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of respiratory care 2022-10, Vol.11 (4), p.353-357
Hauptverfasser: Kumar, Anuj, Saini, Varinder, Aggarwal, Deepak, Palta, Anshu, Jindal, Rohit, Sodhi, Mandeep Kaur
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Osteoporosis has been widely reported in chronic respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis. However, there is a scarcity of data on its prevalence and risk factors in interstitial lung disease (ILD), particularly in Indian patients. Aims: The present study was conducted to determine the prevalence and predictors of osteoporosis in ILD patients. Materials and Methods: We conducted a cross-sectional study, in which ILD patients presenting to the hospital were enrolled. After collecting demographic and clinical data, the patients underwent a dual-energy x-ray absorptiometry scan of the femoral neck to measure bone mineral density. Osteoporosis was diagnosed based on their T-scores, following the World Health Organization guidelines. Univariate and multivariate logistic regression analyses were performed to determine the risk factors of osteoporosis in ILD. Results: The mean age of the 97 ILD patients was 55.7 + 12.6 years (range 28–84 years) with the predominance of females (n = 61). Osteoporosis was detected in 39 (40.2%) patients. Female gender, duration of symptoms, and low hemoglobin level had a positive association with osteoporosis on univariate analysis (P < 0.05). However, duration of symptoms (adjusted odds ratio [OR]-1.29; 95% confidence interval CI-1.02–1.63; P = 0.04) and hemoglobin level (adjusted OR-0.59; 95% CI-0.39–0.89; P = 0.01) were the independent risk factors of osteoporosis on multivariate analysis. Conclusion: Osteoporosis is common comorbidity seen in ILD patients. A longer duration of ILD symptoms and low hemoglobin level can predict the presence of osteoporosis in these patients.
ISSN:2277-9019
2321-4899
DOI:10.4103/ijrc.ijrc_86_22